Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07344233 · ClinicalTrials.gov registry record · NA
Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin Addiction
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT07344233 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 28 participants.
The verdict
NCT07344233, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Support groups are an important component of addiction treatment, where individuals at more stable stages of their recovery help others by sharing personal experiences. This phenomenon suggests that the brain states of individuals further along in their recovery process may be useful in guiding those who are at an earlier stage. In this project, the researchers will test this idea and develop a personalized therapeutic tool based on real-time fMRI neurofeedback, whereby individuals with heroin use disorder (iHUD) early in treatment will learn to modulate their own brain state to more closely align with iHUD who are at later stages of treatment. Specifically, iHUD exhibit heightened reactivity to naturalistic drug cues in brain networks underlying salience attribution, reward processing, executive function and others. This fMRI brain hyperactivity pattern is reduced, concomitant with craving reductions, with about 3 months of inpatient treatment. In this neurofeedback project, iHUD who are beginning treatment will view naturalistic drug cues and receive feedback about how similar their brain activity is to the target recovery pattern, learning to modulate their own brain activity to reduce drug cue reactivity and craving. This study will offer insights into the mechanisms of recovery in addiction, particularly as coordinated across individuals with shared experience and goals. If successful, the neurofeedback-based training may lead to new brain-based and personalized tools for recovery in this devastating disorder.
Interventions
- BEHAVIORAL Real-time fMRI Neurofeedback
- BEHAVIORAL Sham Real-time fMRI Neurofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2025-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07344233
The ClinicalTrials.gov registry entry for NCT07344233 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Real-time fMRI Neurofeedback is the first listed.
NCT07344233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07344233 about?
NCT07344233 is a clinical study titled "Neurofeedback During Naturalistic Stimuli to Reduce Craving in Heroin Addiction". Support groups are an important component of addiction treatment, where individuals at more stable stages of their recovery help others by sharing personal experiences. This phenomenon suggests that the brain states of individuals further along in their recovery process may be useful in guiding thos...
What is the current status of trial NCT07344233?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2025-05-20. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT07344233?
The interventions under investigation include: Real-time fMRI Neurofeedback (BEHAVIORAL), Sham Real-time fMRI Neurofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT07344233?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.